The distinct therapeutic, clinical, and research worlds of BA metabolism and viral hepatitis unexpectedly converged in 2014 when Yan et al192 discovered that the membrane receptor for HBV is NTCP. The gene discussed is SLC10A1; the disease is viral hepatitis.